Loading organizations...
HillCour is a holding company that invests in and manages healthcare-related businesses, based in Lakeland, FL, with related entities in Tampa, FL. It oversees operating companies providing health and wellness solutions, including integrated pharmacy networks, formulary reviews, customized reporting, and online health information access. Through HillCour Holding Corp. and HillCour Investment Fund LLC, it holds stakes in pharmacy benefit managers, third-party administrators, and other healthcare services. The company has engaged in significant transactions, including the 2017 sale of WellDyneRx to Carlyle and a 2021 investment in Marpai's IPO, later selling Continental Benefits to Marpai. In March 2024, HillCour Investment Fund LLC, controlled by Damien Lamendola, entered a securities purchase agreement with Marpai. Key figures include CEO Damien Lamendola, CFO Steve Johnson, and Yaron Eitan; the company was founded in 1990.
HillCour has 1 tracked investment across 1 company. The latest tracked deal is $15.0M Series A in Thirty Madison in October 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2018 | Thirty Madison | $15.0M Series A | Jason Stoffer, Northzone | Animoca Brands, Foobar.vc, Greylock, Lightspeed Venture Partners, Makers Fund, David LAU KEE, JOI ITO, BEN Cogan, Divya Gugnani, ERA, First Round, Greycroft, Steadfast Venture Capital, TWO River |
